(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HELIOLIVER

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

HELIOLIVER

ST13

US500000097701003

Class

44

Filing

97701003

Registration

7681157

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

02/04/2025

Classification

Registered

Trademark type

Word

Nice classes

44

Filing date

12/02/2022

Registration date

02/04/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/04/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/16/2022

First use in commerce

01/16/2022

Drawing code

4

Owner type

03

Owner location

Irvine, CA

Examiner

VAN DEN ABEELEN, DEREK

Law office

N80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Helio Health Inc.

Representatives

Scott Pink O'MELVENY & MYERS, LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical diagnostic testingmonitoring and reporting services for the detection of cancer using blood samples; medical screening and diagnostic services for the diagnosis of cancerproviding testing services to detect the presence of cancer in an individual based on the analysis of blood samples using artificial intelligence and the detection of cfDNA methylation markers

Publications

History of USPTO decisions and trademark events.

29 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/13/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/13/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/06/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/06/2024

IUAF

USE AMENDMENT FILED

09/25/2024

EISU

TEAS STATEMENT OF USE RECEIVED

09/25/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/19/2024

EX1G

SOU EXTENSION 1 GRANTED

09/19/2024

EXT1

SOU EXTENSION 1 FILED

09/19/2024

EEXT

SOU TEAS EXTENSION RECEIVED

09/19/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/19/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/23/2024

PUBO

PUBLISHED FOR OPPOSITION

01/23/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/21/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/20/2023

GNSL

LETTER OF SUSPENSION E-MAILED

06/20/2023

CNSL

SUSPENSION LETTER WRITTEN

06/20/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/17/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/16/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/16/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/19/2023

GNRT

NON-FINAL ACTION E-MAILED

03/19/2023

CNRT

NON-FINAL ACTION WRITTEN

03/19/2023

DOCK

ASSIGNED TO EXAMINER

03/18/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/28/2022

NWAP

NEW APPLICATION ENTERED

12/06/2022

Continuous trademark protection

Get notified about every new filing that threatens HELIOLIVER or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.